Skip to Main Content

Hello, everyone, and how are you today? We are doing just fine, thank you, now that a warm and shiny sun has risen over the otherwise chilly Pharmalot campus. Moreover, our short people have scurried off to their destinations, our official mascot is happily snoozing on his couch, and our coffee kettle is heating up another cup of stimulation — almond toffee is our choice today. So this brings us to the task at hand, which is to forage for interesting items. Speaking of which, here are some tidbits. Have a lovely day and best of luck. …

Purdue Pharma agreed to settle the state of Oklahoma’s claims that its illegal marketing of the Oxycontin painkiller caused financial devastation to local communities, the first accord in a recent wave of lawsuits stemming from the U.S. opioid crisis, according to Bloomberg News. The settlement comes two months before the scheduled start of a trial against Purdue, Johnson & Johnson (JNJ), and Teva Pharmaceutical (TEVA). Oklahoma claims the three opioid makers understated the risks of prescription painkillers and overstated their benefits, fueling an epidemic.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!